Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Long-Term Depletion of Conventional Dendritic Cells Cannot Be Maintained in an Atherosclerotic Zbtb46-DTR Mouse Model.

Rombouts M, Cools N, Grootaert MO, de Bakker F, Van Brussel I, Wouters A, De Meyer GR, De Winter BY, Schrijvers DM.

PLoS One. 2017 Jan 6;12(1):e0169608. doi: 10.1371/journal.pone.0169608.

2.

Dendritic Cell KLF2 Expression Regulates T Cell Activation and Proatherogenic Immune Responses.

Alberts-Grill N, Engelbertsen D, Bu D, Foks A, Grabie N, Herter JM, Kuperwaser F, Chen T, Destefano G, Jarolim P, Lichtman AH.

J Immunol. 2016 Dec 15;197(12):4651-4662.

PMID:
27837103
3.

Engineering nanomaterials to address cell-mediated inflammation in atherosclerosis.

Allen S, Liu YG, Scott E.

Regen Eng Transl Med. 2016 Mar;2(1):37-50.

4.

Linking CD11b (+) Dendritic Cells and Natural Killer T Cells to Plaque Inflammation in Atherosclerosis.

Rombouts M, Ammi R, Van Brussel I, Roth L, De Winter BY, Vercauteren SR, Hendriks JM, Lauwers P, Van Schil PE, De Meyer GR, Fransen E, Cools N, Schrijvers DM.

Mediators Inflamm. 2016;2016:6467375. doi: 10.1155/2016/6467375.

5.

Macrophage Phenotype and Function in Different Stages of Atherosclerosis.

Tabas I, Bornfeldt KE.

Circ Res. 2016 Feb 19;118(4):653-67. doi: 10.1161/CIRCRESAHA.115.306256. Review.

6.

Plaque Size Is Decreased but M1 Macrophage Polarization and Rupture Related Metalloproteinase Expression Are Maintained after Deleting T-Bet in ApoE Null Mice.

Tsaousi A, Hayes EM, Di Gregoli K, Bond AR, Bevan L, Thomas AC, Newby AC.

PLoS One. 2016 Feb 17;11(2):e0148873. doi: 10.1371/journal.pone.0148873.

7.

Decrease in circulating myeloid dendritic cell precursors in patients with intracranial large artery atherosclerosis.

Zhang JX, Li BL, Lin ZQ, Zhang N, Peng X, Gong ZH, Long LC, Zhou X, Xiang DC.

Int J Clin Exp Pathol. 2015 Sep 1;8(9):11495-502.

8.

RNY-derived small RNAs as a signature of coronary artery disease.

Repetto E, Lichtenstein L, Hizir Z, Tekaya N, Benahmed M, Ruidavets JB, Zaragosi LE, Perret B, Bouchareychas L, Genoux A, Lotte R, Ruimy R, Ferrières J, Barbry P, Martinez LO, Trabucchi M.

BMC Med. 2015 Oct 8;13:259. doi: 10.1186/s12916-015-0489-y.

9.

Monocyte-Derived Dendritic Cells Upregulate Extracellular Catabolism of Aggregated Low-Density Lipoprotein on Maturation, Leading to Foam Cell Formation.

Haka AS, Singh RK, Grosheva I, Hoffner H, Capetillo-Zarate E, Chin HF, Anandasabapathy N, Maxfield FR.

Arterioscler Thromb Vasc Biol. 2015 Oct;35(10):2092-103. doi: 10.1161/ATVBAHA.115.305843.

10.

Foamy monocytes form early and contribute to nascent atherosclerosis in mice with hypercholesterolemia.

Xu L, Dai Perrard X, Perrard JL, Yang D, Xiao X, Teng BB, Simon SI, Ballantyne CM, Wu H.

Arterioscler Thromb Vasc Biol. 2015 Aug;35(8):1787-97. doi: 10.1161/ATVBAHA.115.305609.

11.

Beyond vascular inflammation--recent advances in understanding atherosclerosis.

Wolf D, Zirlik A, Ley K.

Cell Mol Life Sci. 2015 Oct;72(20):3853-69. doi: 10.1007/s00018-015-1971-6. Review.

12.

Human monocyte-derived dendritic cells turn into foamy dendritic cells with IL-17A.

Salvatore G, Bernoud-Hubac N, Bissay N, Debard C, Daira P, Meugnier E, Proamer F, Hanau D, Vidal H, Aricò M, Delprat C, Mahtouk K.

J Lipid Res. 2015 Jun;56(6):1110-22. doi: 10.1194/jlr.M054874.

13.

Filter-Dense Multicolor Microscopy.

Kijani S, Yrlid U, Heyden M, Levin M, Borén J, Fogelstrand P.

PLoS One. 2015 Mar 4;10(3):e0119499. doi: 10.1371/journal.pone.0119499.

14.

Probucol Protects Against Atherosclerosis Through Lipid-lowering and Suppressing Immune Maturation of CD11c+ Dendritic Cells in STZ-induced Diabetic LDLR-/- Mice.

Zhu H, Jin X, Zhao J, Dong Z, Ma X, Xu F, Huang W, Liu G, Zou Y, Wang K, Hu K, Sun A, Ge J.

J Cardiovasc Pharmacol. 2015 Jun;65(6):620-7. doi: 10.1097/FJC.0000000000000234.

15.

Classical and Alternative Activation and Metalloproteinase Expression Occurs in Foam Cell Macrophages in Male and Female ApoE Null Mice in the Absence of T and B Lymphocytes.

Hayes EM, Tsaousi A, Di Gregoli K, Jenkinson SR, Bond AR, Johnson JL, Bevan L, Thomas AC, Newby AC.

Front Immunol. 2014 Oct 28;5:537. doi: 10.3389/fimmu.2014.00537.

16.

MHC Class II-restricted antigen presentation by plasmacytoid dendritic cells drives proatherogenic T cell immunity.

Sage AP, Murphy D, Maffia P, Masters LM, Sabir SR, Baker LL, Cambrook H, Finigan AJ, Ait-Oufella H, Grassia G, Harrison JE, Ludewig B, Reith W, Hansson GK, Reizis B, Hugues S, Mallat Z.

Circulation. 2014 Oct 14;130(16):1363-73. doi: 10.1161/CIRCULATIONAHA.114.011090.

17.

Nocardia brasiliensis induces formation of foamy macrophages and dendritic cells in vitro and in vivo.

Meester I, Rosas-Taraco AG, Salinas-Carmona MC.

PLoS One. 2014 Jun 17;9(6):e100064. doi: 10.1371/journal.pone.0100064.

18.

Dendritic cells in atherosclerotic inflammation: the complexity of functions and the peculiarities of pathophysiological effects.

Chistiakov DA, Sobenin IA, Orekhov AN, Bobryshev YV.

Front Physiol. 2014 May 27;5:196. doi: 10.3389/fphys.2014.00196. Review.

19.

Mechanisms that regulate macrophage burden in atherosclerosis.

Randolph GJ.

Circ Res. 2014 May 23;114(11):1757-71. doi: 10.1161/CIRCRESAHA.114.301174. Review.

20.

The dynamic lives of macrophage and dendritic cell subsets in atherosclerosis.

Taghavie-Moghadam PL, Butcher MJ, Galkina EV.

Ann N Y Acad Sci. 2014 Jun;1319:19-37. doi: 10.1111/nyas.12392. Review.

Supplemental Content

Support Center